dr alison moskowitz discusses when to use brentuximab vedotin in hodgkin lymphoma
Published 5 years ago • 234 plays • Length 3:15Download video MP4
Download video MP3
Similar videos
-
11:21
debate: brentuximab vedotin as upfront therapy for advanced hodgkin lymphoma? - yes
-
2:13
dr alison moskowitz discusses survival disparities in hodgkin lymphoma
-
1:58
dr alison moskowitz on treatments more likely to cause neutropenia in hodgkin lymphoma
-
3:29
dr alison moskowitz: standard of care for hodgkin lymphoma depends on stage of disease, patient age
-
15:15
debate: best second-line approach to induce lymphoma remission prior to sct? - brentuximab
-
9:09
brentuximab vedotin for advanced hodgkin lymphoma in the echelon-1 study
-
6:59
doctor explains how hodgkin lymphoma spreads, plus risk factors & treatment options | stanford
-
19:02
i had symptoms for months! samantha's non-hodgkin lymphoma story | the patient story
-
3:53
debunking 5 myths about lymphoma
-
5:31
what is follicular lymphoma exactly?
-
2:43
hodgkin lymphoma: using brentuximab vedotin frontline
-
1:05
dr. moskowitz on important updates in hodgkin lymphoma
-
1:50
dr alison moskowitz on the importance of patients understanding their diagnosis, treatment options
-
6:24
joseph connors, md: bleomycin or brentuximab vedotin in hodgkin lymphoma?
-
6:37
clinical cases employing novel agents in hodgkin lymphoma
-
1:31
dr. moskowitz on the alcanza trial in ctcl
-
2:31
brentuximab for second-line lymphoma treatment
-
12:21
non-hodgkin lymphoma - causes, symptoms, diagnosis, treatment, pathology
-
10:43
five year update of echelon-1 for classical hodgkin lymphoma
-
50:17
update on hodgkin lymphoma | lrf webinars
-
9:31
hodgkin’s lymphoma - hodgkin’s disease - reed-sternberg cell - hematology and oncology
-
2:25
warning signs of lymphoma